Columna Capital Analysis
What is Columna Capital?
European lower mid-market private equity investor focused on growth and consolidation
Location
London, United Kingdom
Employees
11-50
Founded
2009
Product Features & Capabilities
- Investment in profitable lower mid-market European companies
- Focus on growth and consolidation opportunities
- Target revenue range of €15-100 million
- Long-term partnership with management teams
- Geographic focus on continental Europe
Use Cases
Invest in agri-food companies with €50M revenue; Support animal health startups in Switzerland; Acquire and consolidate insurance service providers; Fund healthcare innovation in senior living; Drive expansion of home dialysis technology
Other Considerations
Fund III closed at €290M; Invested in 10+ portfolio companies; Portfolio includes Santévet, Zumex, Physidia, MSA Mizar, Over; Active in pan-European market expansion; Recognized in MergerMarket’s Unquote
See something that needs updating? Suggest edits to this profile.